Improved Relapse-Free Survival (RFS) for Pediatric and Young Adult Patients with Relapsed or Refractory (R/R) B-Cell Acute Lymphoblastic Leukemia (B-ALL) and Low or Intermediate Preinfusion Disease Burden Treated with Tisagenlecleucel: Results from the CIBMTR Registry
Authors:
- Samuel JohnSJSamuel John
- Michael HeimMHMichael Heim
- Kevin J. CurranKCKevin J. Curran
- Erin M. HallEHErin M. Hall
- Amy K. KeatingAKAmy K. Keating
- Susanne H.C. BaumeisterSBSusanne H.C. Baumeister
- Sarah NikiforowSNSarah Nikiforow
- Timothy DriscollTDTimothy Driscoll
- Amy MoskopAMAmy Moskop
- Kevin O. McNerneyKMKevin O. McNerney
- Christine L PhillipsCPChristine L Phillips
- Michael PulsipherMPMichael Pulsipher
- 5 February 2023
- journal article
- abstracts
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 29 (2) , S37-S38